|
|
|
| Usage analysis of oral Chinese patent medicine in Pediatric Outpatient of our hospital |
| ZOU Bingzi |
| Department of Pharmacy, Beijing Fengtai District Maternal and Child Health Hospital, Beijing 100069, China |
|
|
|
Abstract Objective To understand the use of oral Chinese patent medicine in Pediatric Outpatient prescription of Beijing Fengtai District Maternal and Child Health Hospital (hereinafter referred to as “our hospital”), and analyze the existing problems and provide guarantee for strengthening the clinical rational and safe use. Methods Nine hundred and sixty prescriptions of oral Chinese patent medicine were randomly selected through hospital information system of our hospital from July 2018 to June 2019. According to the different ages of children, the use of drug action category, dosage form, toxic ingredients and unreasonable prescription were analyzed. Results There were 41 kinds of special oral Chinese patent medicines for children in our hospital, accounting for 19.34% of the total Chinese patent medicines in our hospital. In the prescription of oral Chinese patent medicine, action category and dosage form rank first were 329 pieces of antitussive, expectorant and antiasthmatic drugs (34.27%) and 18 kinds of granules (43.90%); there were 16 kinds of drugs containing toxic ingredients, including 14 kinds of oral drugs and 2 kinds of external drugs; there were 10 medicines containing bitter almonds; among them, there were 56 unreasonable prescriptions, accounting for the proportion of the prescriptions sampled 5.83%; the main problems were incomplete clinical diagnosis, inappropriate usage and dosage, inappropriate drug selection, etc. Conclusion The use of oral Chinese patent medicine in pediatrics of our hospital is generally reasonable, but because of the limitation of specialty, the Western medicine division is not reasonable in the use of Chinese patent medicine, so it is necessary to strengthen the training of Chinese medicine knowledge of Western medicine division to ensure that Chinese patent medicine is more reasonable and safe in the clinical use of pediatrics.
|
|
|
|
|
|
[1] 史学.儿科常用中成药的合理应用[J].儿科药学杂志，2016，22（3）：19-20.
[2] 刘晶，赵宇燕.儿科应用中成药的现状调查[J].光明中医，2018，33（8）：1073-1074.
[3] 中华人民共和国卫生部.处方管理办法[S].卫生部令第53号.2007-02-14.
[4] 中华人民共和国卫生部.医院处方点评管理规范（试行）[S].卫医管发[2010]28号.2010-02-10.
[5] 国家中医药管理局.中成药临床应用指导原则[S].国中医药医政发[2010]30号.2010-06-11.
[6] 金锐，赵奎君，郭桂明，等.中成药临床合理用药处方点评北京共识[J].中国中药杂志，2018，43（5）：1049-1053.
[7] 国家药典委员会.中华人民共和国药典[M].一部.北京：中国医药科技出版社，2015.
[8] 王大力.2015年至2017年我院儿科门诊中成药应用情况分析[J].现代医学与健康研究，2018，2（18）：133-134.
[9] 蒋澜，刘晓峰.深圳市南山区妇幼保健院儿童中成药使用调查与分析[J].中医儿科杂志，2019，15（4）：78-81.
[10] 高学敏，马融，张德芹.我国儿童中成药用药现状、存在问题及解决建议[J].中成药，2016，38（5）：1192-1196.
[11] 郑红玲.临床儿科应用中成药的存在问题和建议[J].医药论坛杂志，2016，37（9）：161-163.
[12] 田虹，田侃.浅议完善含有毒药材的儿童用中成药的管理规范[J].中国药房，2014，25（23）：2203-2205.
[13] 金锐，王宇光，薛春苗，等.中成药处方点评的标准与尺度探索（十）：儿童用药[J].中国医院药学杂志，2017，37（11）：1003-1008.
[14] 张泰，连佳.儿科应用清热类中成药存在的问题及建议[J].中医杂志，2017，58（2）：119-122.
[15] 刘万福.探讨中成药标准中儿童用量问题[J].中国处方药，2019，17（11）：30-31.
[16] 李艳，宋亚刚，苗明三.基于临床用药特点的儿科中成药思考[J].中国实验方剂学杂志，2019，25（15）：210-216.
[17] 郭春彦，王彦青，张萌，等.中成药在儿科应用现状的思考与建议[J].中国药学杂志，2017，52（4）：327-330.
[18] 陈佳.中成药在儿科中应用的初步研究[J].海峡药学，2019，31（10）：210-220.
[19] 程华尧，朱灿阳.海南省妇女儿童医学中心门急诊儿童中成药临床应用分析[J].安徽医药，2019，23（10）：2101-2104.
[20] 刘佳，刘桦.1200张儿科中成药处方点评与分析[J].中国医院用药评价与分析，2017，17（5）：703-705.
[21] 林志健，周伟龙，张冰，等.中成药说明书中儿童用药信息的修订完善思考[J].药物流行病学杂志，2018，27（4）：244-248.
[22] 欧玲，邓秀珍.常规药物说明书中儿童用药信息标注情况调查及用药风险[J].海峡药学，2017，29（6）：220-222. |
|
|
|
